| Alicia Elaine Wilson, MS | |
|
1040 Sw 4th St, Moore, OK 73160-2405 | |
| (405) 736-8478 | |
| Not Available |
| Full Name | Alicia Elaine Wilson |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1040 Sw 4th St, Moore, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609352806 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 4117 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Alicia Elaine Wilson, MS 1040 Sw 4th St, Moore, OK 73160-2405 Ph: (405) 735-8478 | Alicia Elaine Wilson, MS 1040 Sw 4th St, Moore, OK 73160-2405 Ph: (405) 736-8478 |
News Archive
The Food and Drug Administration today approved the use of Zostavax, a live attenuated virus vaccine, for the prevention of shingles in individuals 50 to 59 years of age. Zostavax is already approved for use in individuals 60 years of age and older.
The Center for Clinical and Translational Science, or CCTS, at the University of Illinois at Chicago will receive $22 million in new funding from the National Institutes of Health, or NIH, to continue its work supporting critical clinical and translational health research programs.
Young children with multiple disabilities who are enrolled in Head Start have better literacy, reading and math scores than children who aren't in the federally funded program, indicates a new study by Michigan State University researchers.
Four master's students and one doctoral candidate from the UNC Gillings School of Global Public Health shared their global health research and insights at the culmination of a 10-week joint fellowship with IntraHealth International this Wednesday during a poster exhibition and discussion with faculty and staff.
Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative pain treatments, today announced its plans for the commercialization of SPRIX (ketorolac tromethamine) Nasal Spray and OXAYDO (oxycodone HCI, USP) tablets for oral use only –CII.
› Verified 5 days ago
Mrs. Allison Clanton Deimund, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9201 S I 35 Service Rd, Moore, OK 73160 Phone: 405-601-4303 | |
Carolyn Durbin, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2316 Eastridge Cir, Moore, OK 73160 Phone: 405-476-4044 | |
Mrs. Rachael Kathleen Mclean, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1040 Sw 4th St, Moore, OK 73160 Phone: 405-735-6333 Fax: 405-735-6629 | |
Mrs. Tera Leann Underwood, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 604 S Classen Ave, #a, Moore, OK 73160 Phone: 405-735-6333 | |
Elizabeth Hall, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2111 Riverwalk Dr, Moore, OK 73160 Phone: 405-793-7885 | |
Alesa Deon Mcphail, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3204 Marilyn Dr, Moore, OK 73160 Phone: 405-650-9022 | |
Kylee Sullivan, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 400 N Eastern Ave, Moore, OK 73160 Phone: 580-367-0041 |